Mitral Valve Prolapse 2; Mvp2
Description
Patients with MVP2 have nonsyndromic MVP of variable severity inherited as an autosomal dominant trait.For a general phenotypic description and discussion of genetic heterogeneity of mitral valve prolapse, see MVP1 (OMIM ).
Clinical Features
Phenotypes and symptoms related to Mitral Valve Prolapse 2; Mvp2
- Congestive heart failure
- Mitral valve prolapse
- Mitral regurgitation
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Mitral Valve Prolapse 2; Mvp2 Is also known as myxomatous mitral valve prolapse 2, mitral valve prolapse, myxomatous 2, mmvp2.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Mitral Valve Prolapse 2; Mvp2 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Periventricular nodular heterotopia (NGS panel of 8 genes).
By CGC Genetics (Portugal).
DCHS1, ARFGEF2, ERMARD, FAT4, FLNA, FMR1, LRP2, NEDD4L
Specificity
13 %
Genes
100 % |
Periventricular nodular heterotopia (NGS panel of 8 genes).
By CGC Genetics (Portugal).
DCHS1, ARFGEF2, ERMARD, FAT4, FLNA, FMR1, LRP2, NEDD4L
Specificity
13 %
Genes
100 % |
Van Maldergem Syndrome (Cerebro-Facio-Articular Syndrome) via DCHS1 Gene Sequencing with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
DCHS1
Specificity
100 %
Genes
100 % |
Van Maldergem syndrome 1 Deletion / Duplication Test.
By Connective Tissue Gene Tests (United States).
DCHS1
Specificity
100 %
Genes
100 % |
Van Maldergem syndrome 1 NGS Test.
By Connective Tissue Gene Tests (United States).
DCHS1
Specificity
100 %
Genes
100 % |
Mitral valve prolapse 2 Comprehensive Test.
By Connective Tissue Gene Tests (United States).
DCHS1
Specificity
100 %
Genes
100 % |
Mitral valve prolapse 2 Deletion / Duplication Test.
By Connective Tissue Gene Tests (United States).
DCHS1
Specificity
100 %
Genes
100 % |
Van Maldergem syndrome 1 Comprehensive Test.
By Connective Tissue Gene Tests (United States).
DCHS1
Specificity
100 %
Genes
100 % |
You can get up to 9 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
MESH OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like THOMSEN AND BECKER DISEASE